• Home
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.

Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.

Author List
Brevet M, Shimizu S, Bott MJ, Shukla N, Zhou Q, Olshen AB, Rusch V, Ladanyi M
Publication
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1486871
Publication Year
2011
PubMed ID
21774103
Publication Title
Brevet M, Shimizu S, Bott MJ, Shukla N, Zhou Q, Olshen AB, Rusch V, Ladanyi M. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. J Thorac Oncol. 2011 May; 6(5):864-74.